ARCHIVES

Phase III Study: Lymphoseek Superior to Vital Blue Dye

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981

New Jersey Center Takes Slice of DOE Budget for Cancer

January 8, 1988

President Proposes $1 Billion Increase For NIH In FY2011; Cancer A High Priority

February 5, 2010

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009